U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Warfarin Management in Patients with Atrial Fibrillation — Current Practice Study [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2012 Mar. (CADTH Optimal Use Report, No. 1.2D.)

Cover of Warfarin Management in Patients with Atrial Fibrillation — Current Practice Study

Warfarin Management in Patients with Atrial Fibrillation — Current Practice Study [Internet].

Show details

2BACKGROUND

Optimizing drug-related health outcomes and cost-effective use of drugs by identifying and promoting optimal drug prescribing and use is a goal of CADTH. Where possible, CADTH builds on existing applicable Canadian and international initiatives and research. CADTH goals are achieved through three main approaches:

  • identifying evidence-based optimal use in prescribing and use of specific drugs
  • identifying gaps in clinical practice, then proposing evidence-based interventions to address these gaps
  • supporting the implementation of these interventions.

Direction and advice are provided to CADTH through various channels, including the following:

  • the Drug Policy Advisory Committee (DPAC), the DPAC Optimal Use Working Group (OUWG), and the Formulary Working Group (FWG),which include representatives from the federal, provincial, and territorial health ministries and related health organizations
  • the COMPUS Expert Review Committee (CERC) (members are listed in Appendix A)
  • stakeholder feedback.

2.1. COMPUS Expert Review Committee

CERC consists of eight Core Members appointed to serve for all topics under consideration during their term of office, and three or more Specialist Experts appointed to provide their expertise in recommending optimal use for one or more specific topics. For this project, five Specialist Experts were appointed; their expertise included cardiology, hematology, and thrombosis. Two of the Core Members are Public Members, who bring a lay perspective to the committee. The remaining six Core Members hold qualifications as physicians, pharmacists, or health economists, or have other relevant qualifications, with expertise in one or more areas such as, but not limited to, family practice, internal medicine, institutional or community clinical pharmacy, pharmacoeconomics, clinical epidemiology, drug utilization, methodology, affecting behaviour change (through health professional and/or patient and/or policy interventions), and critical appraisal. The Core Members, including Public Members, are appointed by the CADTH Board of Directors.

CERC’s mandate is advisory in nature and consists of providing recommendations and advice to CADTH on assigned topics that relate to the identification, evaluation, and promotion of optimal practices in the prescribing and use of drugs across Canada. The overall perspective of CERC members in producing recommendations is that of public health care policy-makers in pursuit of optimizing the health of Canadians within available health care system resources.

Copyright © CADTH 2011.

Except where otherwise noted, this work is distributed under the terms of a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International licence (CC BY-NC-ND), a copy of which is available at http://creativecommons.org/licenses/by-nc-nd/4.0/

Bookshelf ID: NBK361752

Views

  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (1.0M)

Other titles in this collection

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...